These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2396063)

  • 21. Public financing of dental care: impact and policy implications.
    Bailit H; Edelstein B; Tinanoff N
    J Dent Educ; 1999 Dec; 63(12):882-9. PubMed ID: 10650413
    [No Abstract]   [Full Text] [Related]  

  • 22. Health insurance oversight issue brief: mandated benefits: off-label drug coverage requirements: year end report--2004.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15726733
    [No Abstract]   [Full Text] [Related]  

  • 23. New federal guidelines: a green light from government.
    Gosselin RA
    Hosp Formul; 1978 Jul; 13(7):546-9. PubMed ID: 10308293
    [No Abstract]   [Full Text] [Related]  

  • 24. Affordable prescription drugs--state and federal action.
    Ohio Nurses Rev; 2003 Aug; 78(7):4. PubMed ID: 15134064
    [No Abstract]   [Full Text] [Related]  

  • 25. MAC study confirms pharmacy losses.
    Torielli G; Gagnon JP; Lingle EW
    Am Pharm; 1982 Aug; NS22(8):31-3. PubMed ID: 6751062
    [No Abstract]   [Full Text] [Related]  

  • 26. Disease management. Getting out from under drug companies' shadows.
    Heimoff S
    Manag Care; 2000 Mar; 9(3):39-40, 42-3. PubMed ID: 11066212
    [No Abstract]   [Full Text] [Related]  

  • 27. Pricing and reimbursement of pharmaceuticals in Italy.
    Folino-Gallo P; Montilla S; Bruzzone M; Martini N
    Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHIPS awarded 31.7 million dollars to help beneficiaries about new drug coverage.
    Miss RN; 2005; 67(2):17. PubMed ID: 16047853
    [No Abstract]   [Full Text] [Related]  

  • 29. Time to leave the capsule ... if you dare.
    McCarthy R
    Bus Health; 1991 Sep; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to pay for national pharmacare.
    Wolfson MC; Morgan SG
    CMAJ; 2018 Nov; 190(47):E1384-E1388. PubMed ID: 30478216
    [No Abstract]   [Full Text] [Related]  

  • 32. Rumors rife on health changes.
    Hughes AD
    Aust Hosp; 1977 Aug; (11):2. PubMed ID: 10305996
    [No Abstract]   [Full Text] [Related]  

  • 33. Big pharma's struggles might benefit health plans.
    Manag Care; 2012 Jan; 21(1):65. PubMed ID: 22334941
    [No Abstract]   [Full Text] [Related]  

  • 34. Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
    Blair L
    Can Fam Physician; 2002 Apr; 48():831, 833, 836-8. PubMed ID: 12046376
    [No Abstract]   [Full Text] [Related]  

  • 35. DTCA not real advertising issue.
    Saunders B
    N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960
    [No Abstract]   [Full Text] [Related]  

  • 36. States combat drug costs.
    Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
    [No Abstract]   [Full Text] [Related]  

  • 37. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the market ready for direct pharmaceutical contracting by employers?
    Giaquinta D
    Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
    [No Abstract]   [Full Text] [Related]  

  • 39. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
    Hamilton C; Lokuge B; Denniss R
    Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
    [No Abstract]   [Full Text] [Related]  

  • 40. Government financing for health and specific national budget lines: the case of vaccines and immunization.
    Lydon P; Beyai PL; Chaudhri I; Cakmak N; Satoulou A; Dumolard L
    Vaccine; 2008 Dec; 26(51):6727-34. PubMed ID: 18625279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.